1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. CorEvitas Acquires Pregistry

M&A Deal Summary

CorEvitas Acquires Pregistry

On November 21, 2022, CorEvitas acquired life science company Pregistry

Acquisition Highlights
  • This is CorEvitas’ 2nd transaction in the Life Science sector.
  • This is CorEvitas’ 3rd transaction in the United States.
  • This is CorEvitas’ 1st transaction in California.

M&A Deal Summary
Date 2022-11-21
Target Pregistry
Sector Life Science
Buyer(s) CorEvitas
Deal Type Add-on Acquisition

Target

Pregistry

Los Angeles, California, United States
Pregistry is a provider of conducting observational studies to assess the safety of medications and vaccines used during pregnancy. Pregistry covers a range of clinical, preclinical, safety, regulatory, marketing, and IT needs, the focus is on healthy and safe pregnancies and babies, and that prescribers have the information needed to be able to explain the potential benefits and risks of medications and vaccines during pregnancy. Pregistry was founded in 2014 and is based in Los Angeles, California.

Search 215,130 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

CorEvitas

Waltham, Massachusetts, United States
Category Company
Founded 2001
Sector Life Science
DESCRIPTION

CorEvitas provides real-world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators. Corona operates six major autoimmune registries across the US, Canada, and Japan, collecting data from over 500 participating investigator sites. CorEvitas was founded in 2001 and is based in Waltham, Massachusetts.

DEAL STATS #
Overall 4 of 4
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 4 of 4
State: California M&A 1 of 1
Country: United States M&A 3 of 3
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-22 Vestrum Health

Naperville, Illinois, United States

Vestrum Health is a provider of data analytics of retina electronic health record (EHR) data, empowers retina practices to optimize clinical performance and patient outcomes by leveraging real-world clinical applications. Vestrum Health’s data provide insightful views across the drug life cycle to biopharmaceutical companies focused on retinal diseases. Vestrum Health was founded in 2014 and is based in Naperville, Illinois.

Buy -
Mergr

Solution for

Product

Company

Legal